KALY Gives Veterans 10 Percent Discount On Hemp4mula CBD Gum and 20 Percent Discount to All Over Memorial Day Weekend
May 24 2019 - 11:06AM
InvestorsHub NewsWire
KALY Gives Veterans 10 Percent
Discount On Hemp4mula CBD Gum and 20 Percent Discount to All Over
Memorial Day Weekend
Hemp4mula CBD Gum Available Through
www.USMJ.com
Memorial Day 20%
Discount Available to All Now Through May
29th
Dallas, TX -- May 24, 2019 -- InvestorsHub
NewsWire -- Kali-Extracts (aka Kali, Inc.)
(USOTC:
KALY) (“KALY”) today announced its Hemp4mula CBD Gum
available to all U.S. Veterans
from here forward at a 10% discount. Hemp4mula is available
online at the Ecommerce site www.USMJ.com hosted by North American Cannabis
Holdings, Inc. (USOTC:
USMJ) (“USMJ”). USMJ has launched a Veteran Discount
Program called Operation Patriotic Salute
extending a 10% discount on all CBD and Cannabis Essentials
available on their website www.USMJ.com. Also, now through May 29th,
in honor of the Memorial Daly Celebration, USMJ is offering a 20%
discount to everybody on all CBD and Cannabis
Essentials.
Go To www.USMJ.com Now For
CBD Infused Products And Cannabis
Essentials.
Patented Cannabis Extracts Targeting $170 In Million
Pharmaceutical
Treatments
In the fourth
quarter of last year, 2018, KALY acquired NCM Biotech (NCMB).
NCMB is biopharmaceutical company focused on discovering,
developing and commercializing novel therapeutics from a
proprietary cannabinoid product platform in a broad range of
disease areas. KALY owns and operates a U.S. Patent
For Cannabis Extraction. In four years of operations, the
company has established a leading position in the development of
plant-derived cannabinoid therapeutics through a proven drug
discovery and patented development process. The resulting
intellectual property portfolio and the established regulatory and
manufacturing expertise have created a significant
opportunity. KALY, through its subsidiary, NCMB has a deep
pipeline of additional cannabinoid product candidates including
four distinct compounds. KALY has completed the first stage
of clinical development and testing for a Chronic Obstructive
Pulmonary Disease (COPD) therapy and is currently conducting phase
one development and trials for compounds targeting Cancer Pain
Management, Type 2 Diabetes and Epilepsy. Separately, to
generate revenue in parallel while ongoing research is conducted,
KALY is launching a line of CBD infused consumer products of which
Hemp4mula Gum is the first. Hemp4mula Gummies are coming soon
as well as HempTantation
Sunscreen.
To learn more
about the company visit https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024